Â鶹ŮÓÅ

President Joe Biden, alongside first lady Jill Biden, delivered remarks Tuesday in New Orleans addressing his revamped "Cancer Moonshot" program, which seeks to cut the cancer death rate in the U.S. by about half over the next 25 years. During the president's remarks, which took place at Tulane University, he focused on the need to break down research "silos" and improve information sharing among the cancer research community. (Schemmel, 8/13)

President Joe Biden’s first public event planned since his exit from the 2024 race last month marked a cause close to home: Announcing a major financial award from the cancer-curing policy arm he created in the wake of his son Beau Biden’s death. (Tausche, 8/13)

The maker of store-brand Mucinex sold by CVS, Walmart and others is reformulating its products to move away from an ingredient that is made with a cancer-causing chemical. Amneal Pharmaceuticals Inc. plans to submit testing data on its new formulation to the US Food and Drug Administration by the end of the year, the company said in a statement. The company expects to bring the products to market before August 2025. (Edney, 8/13)

Cancer detection firm Grail announced sizable workforce cuts on Tuesday in a bid to save cash and concentrate resources on developing a blood-based test to spot early signs of dozens of cancers. (Wosen, 8/13)

Nearly a third of child-cancer hospital admissions in Pennsylvania between 2021 and 2023 were among children from the Philadelphia area, data from a new report shows. Bucks, Chester, Delaware, Montgomery and Philadelphia Counties reported 2,400 child-cancer hospital admissions during the three-year period. Of those, 1,092 admissions were among children from Philadelphia. (Gutman, 8/13)